Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phosphatidylglycerol-rich bacterial membrane domains are specialized, anionic regions within the bacterial cytoplasmic membrane that serve as critical organizational platforms for various physiological processes. These domains are characterized by a high density of phosphatidylglycerol (PG), which facilitates the recruitment and regulation of essential membrane-associated proteins involved in cell division, such as FtsZ and MinD, and cell wall biosynthesis (Müller et al., 2016; Epand et al., 2016). In Gram-positive pathogens like Staphylococcus aureus, these domains are vital for maintaining membrane potential and structural stability. They represent a significant therapeutic target for several classes of antibiotics, most notably the cyclic lipopeptide daptomycin, which requires PG for its calcium-dependent insertion and subsequent oligomerization within the membrane (Humphries et al., 2013). This interaction leads to membrane depolarization, leakage of intracellular ions, and the displacement of peripheral membrane proteins, resulting in rapid bacterial cell death (Pader et al., 2016). While these domains offer a degree of selectivity due to the lower PG content in the outer leaflet of mammalian cells, their similarity to mitochondrial membranes presents a potential challenge for drug safety and development (Seydlová et al., 2019).
Antibiotics targeting these domains typically utilize a multi-step process involving initial electrostatic attraction to the anionic PG headgroups, followed by calcium-dependent insertion or hydrophobic interaction, leading to membrane oligomerization, pore formation, and lethal depolarization of the bacterial cell membrane (Humphries et al., 2013; Müller et al., 2016).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylglycerol-rich bacterial membrane domains (PG-rich domains).